These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9298404)

  • 21. Evaluation of early DNA damage in healthcare workers handling antineoplastic drugs.
    Ursini CL; Cavallo D; Colombi A; Giglio M; Marinaccio A; Iavicoli S
    Int Arch Occup Environ Health; 2006 Nov; 80(2):134-40. PubMed ID: 16761155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary cyclophosphamide excretion and chromosomal aberrations in peripheral blood lymphocytes after occupational exposure to antineoplastic agents.
    Sessink PJ; Cerná M; Rössner P; Pastorková A; Bavarová H; Franková K; Anzion RB; Bos RP
    Mutat Res; 1994 Sep; 309(2):193-9. PubMed ID: 7520976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of environmental contaminations and occupational exposures involved in preparation of chemotherapeutic drugs.
    Maeda S; Miyawaki K; Matsumoto S; Oishi M; Miwa Y; Kurokawa N
    Yakugaku Zasshi; 2010 Jun; 130(6):903-10. PubMed ID: 20519870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter study of environmental contamination with cyclophosphamide, ifosfamide, and methotrexate in 66 Canadian hospitals: A 2016 follow-up study.
    Roland C; Caron N; Bussières JF
    J Occup Environ Hyg; 2017 Aug; 14(8):661-669. PubMed ID: 28574754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limitations of the salmonella/mammalian microsome assay (Ames test) to determine occupational exposure to cytostatic drugs.
    Friederich U; Molko F; Hofmann V; Scossa D; Hann D; Würgler FE; Senn HJ
    Eur J Cancer Clin Oncol; 1986 May; 22(5):567-75. PubMed ID: 3533554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of chromosomal aberrations, sister-chromatid exchanges and micronuclei in peripheral lymphocytes of pharmacists before and after working with cytostatic drugs.
    Roth S; Norppa H; Järventaus H; Kyyrönen P; Ahonen M; Lehtomäki J; Sainio H; Sorsa M
    Mutat Res; 1994 Dec; 325(4):157-62. PubMed ID: 7527908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using a closed-system protective device to reduce personnel exposure to antineoplastic agents.
    Wick C; Slawson MH; Jorgenson JA; Tyler LS
    Am J Health Syst Pharm; 2003 Nov; 60(22):2314-20. PubMed ID: 14652980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring mutagenicity in urine and peripheral blood lymphocytes of pharmacists occupationally exposed to anticancer drugs.
    Elliott G; Ferguson L; Everts R; Edwards R
    N Z Med J; 1990 Jan; 103(882):13-6. PubMed ID: 2406649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exposure of hospital pharmacists and nurses to antineoplastic agents.
    McDevitt JJ; Lees PS; McDiarmid MA
    J Occup Med; 1993 Jan; 35(1):57-60. PubMed ID: 8423505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment.
    Yoshida J; Tei G; Mochizuki C; Masu Y; Koda S; Kumagai S
    Ann Occup Hyg; 2009 Mar; 53(2):153-60. PubMed ID: 19261696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sister chromatid exchanges and chromosome aberrations in lymphocytes of medical personnel handling cytostatic drugs.
    Mahrous HS; Ismail SR; Hashishe MM; Kohail HM
    J Egypt Public Health Assoc; 1998; 73(3-4):297-323. PubMed ID: 17219926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occupational exposure to anticancer drug--potential and real hazards.
    Sorsa M; Hemminki K; Vainio H
    Mutat Res; 1985 Sep; 154(2):135-49. PubMed ID: 3929080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route?
    Sessink PJ; Van de Kerkhof MC; Anzion RB; Noordhoek J; Bos RP
    Arch Environ Health; 1994; 49(3):165-9. PubMed ID: 8185386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees.
    Cavallo D; Ursini CL; Perniconi B; Francesco AD; Giglio M; Rubino FM; Marinaccio A; Iavicoli S
    Mutat Res; 2005 Nov; 587(1-2):45-51. PubMed ID: 16202645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological and environmental monitoring of occupational exposure to cyclophosphamide in industry and hospitals.
    Sorsa M; Pyy L; Salomaa S; Nylund L; Yager JW
    Mutat Res; 1988 Mar; 204(3):465-79. PubMed ID: 3347217
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotoxic hazard evaluation in welders occupationally exposed to extremely low-frequency magnetic fields (ELF-MF).
    Dominici L; Villarini M; Fatigoni C; Monarca S; Moretti M
    Int J Hyg Environ Health; 2011 Dec; 215(1):68-75. PubMed ID: 21862403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of genotoxic risks in Croatian health care workers occupationally exposed to cytotoxic drugs: a multi-biomarker approach.
    Kopjar N; Garaj-Vrhovac V; Kasuba V; Rozgaj R; Ramić S; Pavlica V; Zeljezić D
    Int J Hyg Environ Health; 2009 Jul; 212(4):414-31. PubMed ID: 19049854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No elevation of the frequencies of chromosomal alterations as a consequence of handling cytostatic drugs. Analyses with peripheral blood and urine of hospital personnel.
    Stiller A; Obe G; Boll I; Pribilla W
    Mutat Res; 1983 Sep; 121(3-4):253-9. PubMed ID: 6621588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Environmental and biological monitoring of platinum-containing drugs in two hospital pharmacies using positive air pressure isolators.
    Kopp B; Crauste-Manciet S; Guibert A; Mourier W; Guerrault-Moro MN; Ferrari S; Jomier JY; Brossard D; Schierl R
    Ann Occup Hyg; 2013 Apr; 57(3):374-83. PubMed ID: 23091112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of healthcare workers' exposure to cyclophosphamide, ifosfamide, methotrexate, and 5-fluorouracil by 24-h urine assay: A descriptive pilot study.
    Palamini M; Dufour A; Therrien R; Delisle JF; Mercier G; Gagné S; Caron N; Bussières JF
    J Oncol Pharm Pract; 2020 Dec; 26(8):1864-1870. PubMed ID: 32138611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.